IN2013DE03033A - - Google Patents
Info
- Publication number
- IN2013DE03033A IN2013DE03033A IN3033DE2013A IN2013DE03033A IN 2013DE03033 A IN2013DE03033 A IN 2013DE03033A IN 3033DE2013 A IN3033DE2013 A IN 3033DE2013A IN 2013DE03033 A IN2013DE03033 A IN 2013DE03033A
- Authority
- IN
- India
- Prior art keywords
- drug
- type transdermal
- dia
- active
- transdermal patch
- Prior art date
Links
- 229940079593 drug Drugs 0.000 abstract 4
- 239000003814 drug Substances 0.000 abstract 4
- 239000000064 cholinergic agonist Substances 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 2
- 231100000572 poisoning Toxicity 0.000 abstract 2
- 230000000607 poisoning effect Effects 0.000 abstract 2
- 229960003456 pralidoxime chloride Drugs 0.000 abstract 2
- HIGSLXSBYYMVKI-UHFFFAOYSA-N pralidoxime chloride Chemical compound [Cl-].C[N+]1=CC=CC=C1\C=N\O HIGSLXSBYYMVKI-UHFFFAOYSA-N 0.000 abstract 2
- 238000013268 sustained release Methods 0.000 abstract 2
- 239000012730 sustained-release form Substances 0.000 abstract 2
- SGNXVBOIDPPRJJ-PSASIEDQSA-N 1-[(1r,6r)-9-azabicyclo[4.2.1]non-4-en-5-yl]ethanone Chemical compound CC(=O)C1=CCC[C@@H]2CC[C@H]1N2 SGNXVBOIDPPRJJ-PSASIEDQSA-N 0.000 abstract 1
- PIJVFDBKTWXHHD-UHFFFAOYSA-N Physostigmine Natural products C12=CC(OC(=O)NC)=CC=C2N(C)C2C1(C)CCN2C PIJVFDBKTWXHHD-UHFFFAOYSA-N 0.000 abstract 1
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 239000000599 controlled substance Substances 0.000 abstract 1
- 230000002500 effect on skin Effects 0.000 abstract 1
- 210000004400 mucous membrane Anatomy 0.000 abstract 1
- 229960001697 physostigmine Drugs 0.000 abstract 1
- PIJVFDBKTWXHHD-HIFRSBDPSA-N physostigmine Chemical compound C12=CC(OC(=O)NC)=CC=C2N(C)[C@@H]2[C@@]1(C)CCN2C PIJVFDBKTWXHHD-HIFRSBDPSA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3033DE2013 IN2013DE03033A (enrdf_load_stackoverflow) | 2013-10-10 | 2013-10-10 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3033DE2013 IN2013DE03033A (enrdf_load_stackoverflow) | 2013-10-10 | 2013-10-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013DE03033A true IN2013DE03033A (enrdf_load_stackoverflow) | 2015-04-17 |
Family
ID=54397084
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3033DE2013 IN2013DE03033A (enrdf_load_stackoverflow) | 2013-10-10 | 2013-10-10 |
Country Status (1)
| Country | Link |
|---|---|
| IN (1) | IN2013DE03033A (enrdf_load_stackoverflow) |
-
2013
- 2013-10-10 IN IN3033DE2013 patent/IN2013DE03033A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2013005581A (es) | Sistema terapeutico transdermico para la administracion de una sustancia activa. | |
| MX366560B (es) | Parche adhesivo con composicion antimicrobiana. | |
| WO2011076621A3 (de) | Transdermales therapeutisches system zur verabreichung von rivastigmin oder dessen derivaten | |
| WO2010111178A3 (en) | Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue | |
| NZ611920A (en) | Percutaneous absorption preparation containing rivastigmine | |
| MX2009011857A (es) | Metodo y aparato para formar microconductos multiples. | |
| WO2011069141A3 (en) | Interferon therapies in combination with blockade of stat3 activation | |
| GB2465677B (en) | Non-systemic delivery of satiogens for use in the treatment of obesity and/or diabetes | |
| WO2008151040A3 (en) | Analgesic coated medical product | |
| WO2013036513A3 (en) | Medical bandages with a skin adhesion reducing material | |
| EA201991014A1 (ru) | Лечение диабета | |
| MY160388A (en) | A scaffold material for wound care and/or other tissue healing applications | |
| IN2012DN01225A (enrdf_load_stackoverflow) | ||
| PH12015501169A1 (en) | Transdermal delivery system | |
| MX352824B (es) | Uso de levocetirizina y montelukast en el tratamiento de influenza, resfriado común e inflamación. | |
| NZ603913A (en) | Method of engrafting cells from solid tissues | |
| MX366230B (es) | Composiciones multipolimericas para liberación transdermica de farmaco. | |
| TWD144410S (zh) | 含藥貼布 | |
| MX365688B (es) | Sistemas de administracion de farmaco y metodos para el tratamiento del cancer de vejiga que comprenden oxaliplatino. | |
| WO2011088072A3 (en) | Dermal delivery device | |
| MX367070B (es) | Sistemas de administracion de farmaco y metodos para el tratamiento de la prostata. | |
| WO2014153385A3 (en) | Methods of treating metabolic disorders | |
| AU2014203502B2 (en) | Once-a-day replacement transdermal administration of fentanyl | |
| MX2015010967A (es) | Formulaciones transdermicas de laquinimod. | |
| WO2014123543A3 (en) | Skin permeating and cell entering (space) peptides and methods of use therefor |